Optomed (OHEL:OPTOMED) YoY EPS Growth: 37.50% (As of Mar. 2026)


OHEL:OPTOMED Optomed PLC OHEL:OPTOMED
56 GF Score
Price €1.83
GF Value €3.74
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Optomed YoY EPS Growth?

Optomed OHEL:OPTOMED +10.00% 56 YoY EPS Growth is 37.50% as of Mar. 2026. GuruFocus rates OHEL:OPTOMED with a GF Score™ of 56/100 and a GF Value™ of €3.74 (Possible Value Trap). The stock has 3 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Optomed's YoY EPS Growth for the quarter that ended in Mar. 2026 was 37.50%.

Optomed's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was €-0.05.

Optomed YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Optomed's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Optomed YoY EPS Growth Chart

Optomed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -33.33 -15.63 27.03 -7.41 -17.24

Optomed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.33 20.00 11.11 -100.00 37.50
OHEL:OPTOMED
56GF Score
Optomed PLC OHEL:OPTOMED
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Optomed YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Optomed's YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(-0.34--0.29)/ | -0.29 |
=-17.24 %

Optomed's YoY EPS Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EPS Growth (Q: Mar. 2026 )
=(Earnings per Share (Diluted) (Q: Mar. 2026 )-Earnings per Share (Diluted) (Q: Mar. 2025 )) / | Earnings per Share (Diluted) (Q: Mar. 2025 )) |
=(-0.05--0.08)/ | -0.08 |
=37.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 37.50% mean?
Optomed (OHEL:OPTOMED) has a YoY EPS Growth of 37.50% as of Mar. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Optomed and its competitors.
Is Optomed's YoY EPS Growth too high?
Optomed's current YoY EPS Growth is 37.50%. Overall, Optomed has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Optomed's YoY EPS Growth compare to VEEV and BTSG?
Optomed's YoY EPS Growth of 37.50% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Healthcare Providers & Services company?
A good YoY EPS Growth depends on the Healthcare Providers & Services industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Optomed and its competitors. Optomed's current YoY EPS Growth is 37.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optomed stock overvalued right now?
Based on GuruFocus' analysis, Optomed (OHEL:OPTOMED) is currently considered Possible Value Trap. The stock's GF Value™ is €3.74, compared to a current price of €1.83 — trading 51.2% below its estimated fair value. The current YoY EPS Growth is 37.50%. Optomed's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Optomed (OHEL:OPTOMED), the current YoY EPS Growth is 37.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Optomed (OHEL:OPTOMED) Overvalued in 2026?

Based on GuruFocus' analysis, Optomed stock appears to be undervalued. The current stock price of €1.83 is trading 51.2% below its estimated GF Value™ of €3.74. GuruFocus considers Optomed to be Possible Value Trap.

Key valuation signals for OHEL:OPTOMED:

  • YoY EPS Growth: 37.50%
  • GF Value™: €3.74 vs. price of €1.83 (51.2% below fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the OHEL:OPTOMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Optomed Business Description

Other Exchanges 36U0:Germany
Address Yrttipellontie 1, Oulu, FIN, 90230
Optomed PLC is a Finnish medical technology company and a manufacturer of handheld fundus cameras and screening software. The company provides AI-based screening solutions to support diagnostic processes and early detection. It develops retinal imaging technology that is patented, clinically validated, and has approvals in all key markets, including CE, FDA and NMPA. The company's products are sold via various sales channels in over 60 countries. It has two reportable segments: Devices and Software. The majority of revenue is derived from the Software segment, which offers products for optimal management of various screening operations as well as IT solutions and services for storing, viewing and working with medical images. Geographically, it generates maximum revenue from Finland.
56GF Score

Get the complete analysis for OHEL:OPTOMED

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.83
Price
€3.74
GF Value